If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,425.00
Bid: 2,410.00
Ask: 2,415.00
Change: 0.00 (0.00%)
Spread: 5.00 (0.207%)
Open: 2,460.00
High: 2,460.00
Low: 2,405.00
Prev. Close: 2,425.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorship Changes

12 Dec 2023 07:00

RNS Number : 3963W
Morgan Sindall Group PLC
12 December 2023
 

 

12 December 2023

 

 

Morgan Sindall Group plc

 

Directorship changes

 

Morgan Sindall Group plc (the 'Company') today announces that Steve Crummett, Finance Director, has informed the Board of his intention to retire from the Company on 31 December 2024.

 

The Board also announces that following a search process, Kelly Gangotra, currently Chief Financial Officer, Healthcare Sector at Halma plc and previously Chief Financial Officer of Skanska UK, has been selected to succeed Steve as Finance Director.

 

Kelly will be appointed as Finance Director and become a member of the Board on a date to be agreed, expected to be around the third quarter of 2024, when Steve will step down from both roles. This will then allow for a period of transition until Steve retires from the Company at the end of the year.

 

John Morgan, Group Chief Executive Officer said: "I'd like to thank Steve for his exceptional contribution to the Board over the last ten years. Steve has seen the business through a period of significant growth and has helped shape our strategic direction and ensured that the financial stewardship of the business over the last 10 years has supported the Group's long term growth.

 

"I am delighted that Kelly will join the Group in 2024 and I look forward to working with her over the years ahead. She has an excellent track record as a CFO working in a decentralised business, is highly experienced in the construction and property industry and her valuable and significant skills and insight will support me and the Board as the Group continues to develop and grow." 

 

ENDS

A statement concerning particulars of remuneration payments in accordance with section 430(2B) of the Companies Act 2006 will be published in due course.

 

Note to Editors

Morgan Sindall Group

Morgan Sindall Group plc is a leading UK Construction & Regeneration group with annual revenue of £3.6bn, employing around 7,600 employees and operating in the public, regulated and private sectors. It reports through six divisions of Construction, Infrastructure, Fit Out, Property Services, Partnership Housing and Urban Regeneration.

 

Kelly Gangotra

 

Kelly has extensive financial and commercial leadership experience across the construction and property sectors and has served as the CFO of the Healthcare division of Halma plc since August 2022. Prior to Halma, Kelly spent a decade with Skanska Plc in the UK where she was firstly Finance Director from 2012 to 2015 and then CFO and Executive Vice President between 2015 and 2022. She has also held senior finance roles at Alliance Medical and Biffa Waste Services.

 

There are no other details requiring disclosure under Listing Rule 9.6.13 in relation to Kelly Gangotra.

 

 

 

Morgan Sindall Group

Michael Findlay (Chair)

John Morgan

 

Brunswick

Jonathan Glass

Nina Coad

Tel: 020 7307 9200

 

 

 

Tel: 020 7404 5959

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPGAGPUPWGMG
Date   Source Headline
13th May 20209:00 amRNSAdditional Listing
7th May 20201:30 pmRNSResult of AGM
7th May 20207:00 amRNSAGM Trading Update
1st May 202010:54 amRNSTotal Voting Rights
1st May 202010:37 amRNSChange in Director's details
27th Apr 202010:40 amRNSDisclosure of rights attached to equity shares
20th Apr 20201:10 pmRNSBlock listing Interim Review
2nd Apr 20202:57 pmRNSAnnual Financial Report
1st Apr 202012:08 pmRNSTotal Voting Rights
25th Mar 20207:00 amRNSCOVID-19 Update
11th Mar 20203:45 pmRNSHolding(s) in Company
11th Mar 20208:30 amRNSAdditional Listing
9th Mar 20202:33 pmRNSHolding(s) in Company
9th Mar 20202:13 pmRNSDirector/PDMR Shareholding
3rd Mar 20202:14 pmRNSHolding(s) in Company
2nd Mar 20204:15 pmRNSDirector/PDMR Shareholding
2nd Mar 20204:08 pmRNSDirector/PDMR Shareholding
2nd Mar 20203:19 pmRNSTotal Voting Rights
27th Feb 20202:02 pmRNSHolding(s) in Company
27th Feb 20201:48 pmRNSHolding(s) in Company
27th Feb 20201:39 pmRNSHolding(s) in Company
27th Feb 202010:35 amRNSDirector/PDMR Shareholding
24th Feb 20205:45 pmRNSSophos Group
20th Feb 20207:00 amRNSFinal Results
3rd Feb 20204:20 pmRNSTotal Voting Rights
31st Jan 20203:44 pmRNSHolding(s) in Company
29th Jan 20204:18 pmRNSHolding(s) in Company
24th Jan 20203:25 pmRNSHolding(s) in Company
16th Jan 20207:00 amRNSDirectorate Change
9th Jan 20207:00 amRNSNotice of Results
7th Jan 20204:39 pmRNSHolding(s) in Company
2nd Jan 20208:30 amRNSTotal Voting Rights
21st Nov 20199:21 amRNSDirector/PDMR Shareholding
20th Nov 201911:43 amRNSAdditional Listing
18th Nov 20199:48 amRNSAppointment to c£650m Slough scheme
18th Nov 20197:00 amRNSSenior Management Forum
11th Nov 201912:05 pmRNSHolding(s) in Company
11th Nov 201910:25 amRNSDirector/PDMR Shareholding
6th Nov 20197:00 amRNSTrading Update
1st Nov 20191:58 pmRNSTotal Voting Rights
21st Oct 201910:07 amRNSBlock listing Interim Review
8th Oct 20194:37 pmRNSPrice Monitoring Extension
2nd Oct 20194:08 pmRNSHolding(s) in Company
1st Oct 201910:19 amRNSTotal Voting Rights
3rd Sep 201911:30 amRNSAdditional Listing
2nd Sep 20192:49 pmRNSTotal Voting Rights
13th Aug 20193:34 pmRNSHolding(s) in Company
7th Aug 20197:00 amRNSHalf-year Report
1st Aug 201910:08 amRNSTotal Voting Rights
30th Jul 20194:44 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.